A team of South Korean researchers have concluded that ALA’s efficacy could be highly dependent on how the ingredient is delivered.
Much research has been conducted on alpha-lipoic acid (ALA) for weight management, with previous clinical studies showing reductions in weight, body mass index, blood pressure, and food intake, among other related concerns.
Now, a team of South Korean researchers have concluded that ALA’s efficacy could be highly dependent on how the ingredient is delivered. In a study published last month in the German journal Die Pharmazie, researchers tested the affect of a daily dose of 800 mg of ALA on mice for four months, while monitoring food intake (for appetite suppression).
ALA was formulated using polymeric stabilizers, including hydroxypropyl cellulose, Pluronic F127, and polyvinylpyrrolidone.
The researchers noted that, compared to nanosuspension formulations, polymeric powders demonstrated “improved efficacy” in reducing food intake. These results suggest that such formulations could be candidates for replacing current ALA formulations for achieving appetite suppression.
The Nutritional Outlook Podcast Episode 29: 2024 Ingredients to Watch
January 31st 2024Nutritional Outlook interviews Scott Dicker, market insights director from market researcher SPINS, about ingredients and product categories nutraceutical and nutrition product manufacturers should watch in 2024.
The Link Between Immune Health Benefits & Healthy, Active Lifestyles
January 11th 2024Better immune health means more healthy, active days – and who doesn’t want that? Now, we’re in an era where consumers want to be proactive about their immune health. Nutritional Outlook’s latest podcast highlights one key immune health ingredient, IMMUSE™, that brings a unique mode of action to activate pDCs (plasmacytoid dendritic cells)* — a pivotal leader within the immune system.